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Abstract
Background: Although the prevalence of diabetes is three to five times higher in UK South Asians
than Whites, there are no reports of the extent of ethnicity recording in routine general practice,
and few population-based published studies of the association between ethnicity and quality of
diabetes care and outcomes. We aimed to determine the association between ethnicity and
healthcare factors in an English population.
Methods: Data was obtained in 2002 on all 21,343 diabetic patients registered in 99% of all
computerised general practitioner (GP) practices in three NW London Primary Care Trusts
(PCTs), covering a total registered population of 720,000. Previously practices had been provided
with training, data entry support and feedback. Treatment and outcome measures included drug
treatment and blood pressure (BP), total cholesterol and haemoglobin A1c (HbA1c) levels.
Results: Seventy per cent of diabetic patients had a valid ethnicity code. In the relatively older
White population, we expected a smaller proportion with a normal BP, but BP differences between
the groups were small and suggested poorer control in non-White ethnic groups. There were also
significant differences between ethnic groups in the proportions of insulin-treated patients, with a
smaller proportion of South Asians – 4.7% compared to 7.1% of Whites – receiving insulin, although
the proportion with a satisfactory HbA1c was smaller- 25.6% compared to 37.9%.
Conclusion: Recording the ethnicity of existing primary care patients is feasible, beginning with
patients with established diseases such as diabetes. We have shown that the lower proportion of
South Asian patients with good diabetes control, and who are receiving insulin, is at least partly due
to poorer standards of care in South Asians, although biological and cultural factors could also
contribute. This study highlights the need to capture ethnicity data in clinical trials and in routine
care, to specifically investigate the reasons for these ethnic differences, and to consider more
intensive management of diabetes and education about the disease in South Asian patients.
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Background
Some ethnic groups are at higher risk of developing diabe-
tes. The 1999 Health Survey for England showed that,
compared to the European population, diabetes is more
common in South Asians (the UK Census category for
people from the Indian Sub-Continent). Pakistanis and
Bangladeshis were more than five times as likely to have
diabetes, and in Indians the risk was three times higher
[1]. Rates of diabetes among Black Caribbeans were also
significantly higher than in the general population.
The same factors responsible for the higher prevalence of
diabetes in some ethnic groups may also affect the course
and outcomes of the disease. Relatively little is known
about differences in the intermediate (metabolic) or
longer term outcomes of diabetes in different ethnic
groups, and whether the basis for any differences is
mainly biological, cultural or related to inequalities in
healthcare service delivery. The main reason is the lack of
ethnicity information in epidemiological studies, clinical
trials, and clinical databases.
A recent systematic review [2] reported ethnic differences
in quality and intermediate outcomes of diabetes care to
late 2004. Intermediate clinical outcomes were worse in
Blacks and inclined to be worse in Hispanics. All the stud-
ies reviewed were from the US, and none quoted separate
results for South Asians. Two more recent studies from the
US used ethnicity information collected as part of clinical
care to examine the processes and outcomes of diabetes
care [3,4]. The second quoted ten other US studies of the
effect of ethnicity on diabetes care and outcomes. How-
ever, because the US Census places all Asians and Pacific
Islanders into a single group, none of these studies pro-
vided separate information on the South Asian ethnic
group. Yet because pathophysiology may differ in this
group, as evidenced by the higher prevalence, it is particu-
larly important that both the quality of care and response
to treatment are known.
A study of a London diabetic clinic, i.e. a population
referred for specialist care, showed that South Asians with
type 2 diabetes had poorer glycaemic, BP, and lipid con-
trol than white Europeans [5]. In another UK clinic popu-
lation, glycaemic control was worse in South Asians than
Europeans over time, with average deterioration 1.31% in
Asians vs. 0.82% in Europeans [6]. Moreover, South
Asians had significantly smaller improvements in BP and
cholesterol over the follow-up period, in keeping with
fewer prescriptions of anti-hypertensive agents and lipid-
lowering agents. This suggests that healthcare delivery fac-
tors were at least partly responsible. A third study showed
differences in improvements over time in intermediate
outcomes, and poorer glycaemic control among patients
of South Asian origin [7]. However these were all patients
under the care of hospital diabetologists, and might not
be representative of the entire diabetic population, which
in the UK is largely managed in primary care.
Assessing treatment and outcomes of all diabetic patients
registered for primary care is dependent on the extent of
ethnicity coding as part of routine care delivery. The UK
National Diabetes Audit, which involved 36 PCTs,
attempted to analyse data by ethnicity, but this was
impossible because recording of ethnicity was below 20
per cent in 32 of the 36 participating PCTs [8]. Several UK
reports have attempted to fill this gap using ecological
methods. To investigate the impact of ethnicity on diabe-
tes prevalence, Goyder and Hammersley [9] collected data
from 19 English practices using EMIS clinical information
systems. Information was collected on a range of clinical
data, but ethnicity could only be estimated by using data
from the 1991 Census based on the resident population.
Also in the UK, Hippisley-Cox et al [10] examined the
effect of deprivation and ethnicity on the achievement of
quality of care indicators for patients with diabetes in 237
GP practices included in the QRESEARCH general practice
database. Because of the lack of recorded ethnicity data,
they too used deprivation scores and ethnicity propor-
tions derived from the 2001 Census, both linked to the
Output Areas associated with each patient's postcode, and
showed that patients from high ethnic minority areas had
poorer levels of recording of diabetes care. However use of
Census data to impute patients' ethnicity introduces obvi-
ous inaccuracy. For example, in the UK patients are more
likely to be registered with a GP of their own ethnic group,
introducing another error in attributing ethnicity to prac-
tice populations.
The NHS Diabetes National Service Framework (NSF)
[11] requires that, in addition to intensive glucose control
i.e. an HbA1c less than 7.0%, hypertension and abnormal
lipids should also be treated, with the aim of achieving the
best possible level of overall metabolic control. In addi-
tion, the Quality & Outcomes Framework (QOF) of the
new General Medical Services Contract for GPs incentiv-
ises the achievement of quality standards for diabetes
[12].
We aimed to determine whether ethnicity and processes
of care had independent effects on the NSF short-term
outcome indicators in a multi-ethnic West London dia-
betic population, and if so, to determine which measures
were affected. We used ethnicity information entered into
practice computer systems by practice staff as part of rou-
tine care delivery to investigate the effect of ethnicity on
short-term diabetes outcomes in a population with a large
South Asian ethnic minority group.International Journal for Equity in Health 2007, 6:8 http://www.equityhealthj.com/content/6/1/8
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Methods
Data on diabetes treatment and intermediate outcomes
was obtained from all computerised general practices in
three North West London PCTs- Ealing, Hammersmith &
Fulham and Hounslow- covering a total 2001 Census res-
ident population of 678,000- although the population
actually registered with a GP situated in the three PCTs
was 720,000 (there is a high level of population mobility
in London, with the result that at any one time some
patients are registered with more than one practice).
North West London is an ethnically and socio-economi-
cally diverse area, with large South Asian and significant
Black African/Afro-Caribbean populations. Table 1 shows
2001 Census ethnicity data for residents of the three Lon-
don Boroughs covered by the PCTs. Definitions of ethnic-
ity were changed between the 1991 Census (which have
continued to be used until recently by GP practices to
define the ethnicity of their patients) and the 2001 Cen-
sus. The biggest change in 2001 was the introduction of a
new "Mixed" category, although the proportion who
chose this category was small, and a change from the term
"South Asian" to "Asian".
In November 1997 a chronic disease register (CDR) was
established to offer support to all GP practices in the PCTs.
The CDR supported patient care by downloading pseudo-
anonymised (minus name and address) Read-coded data
from practice systems every quarter using floppy discs
containing Morbidity QUery Information Export SynTax
(MIQUEST) queries, to produce quarterly patient- and
practice-level reports which were re-linked with patient
details by the practices. MIQUEST queries will capture all
correctly-coded information.
At the same time guidance and training on ethnic coding
using 1991 Census codes was disseminated. Feedback to
practices included reports on the completeness of ethnic-
ity and care standards data to encourage improvement.
This feedback, training and some external clerical data
entry support (in part for ethnicity coding) was most
intensive and widespread over the period 2000–2002.
Ethnicity data entry was carried out mainly by GPs, prac-
tice nurses and well-trained clerical staff. Some practices
used patient questionnaires provided to them.
The period studied predates the commencement of the
Quality & Outcomes Framework of the new GP Contract
by almost two years, and no financial incentives were
offered to practices. There were no major efforts to
improve ascertainment or case-finding during the study
period. The 2004–5 UK National Diabetes Audit esti-
mated that 81 percent of the people predicted (utilising
the PBS phase 2 diabetes population prevalence model) to
have diabetes are actually recorded as having diabetes at
GP practices [], and we would expect this proportion to be
registered on the CDR.
Soon after their formation, the seven Primary Care
Groups in the study area, the predecessors of the PCTs, set
an objective of 100 percent practice participation in the
CDR by October 2002. The number of practices included
here is 173 of 178 who were capable/computerised. As the
number of practices participating increased, there was an
increase in the number of diabetic patients identified,
from 13,686 in January 2001 to 21,343 by August 2002.
Both Type 1 and Type 2 diabetes has been included in the
analysis, as have type 1 patients who are children. Gesta-
tional diabetes was not excluded or analysed separately as
Table 1: Summarised 2001 Census ethnicity data for residents of the three London Boroughs
Mixed
Borough 
of 
Residence
White N 
(%)
Asian N 
(%)
Black N 
(%)
Chinese or 
Other N 
(%)
White & 
Black 
Caribbean 
N (%)
White & 
Black 
African N 
(%)
White & 
Asian N 
(%)
Other N 
(%)
All people
Hammers
mith & 
Fulham
128,602 
(77.8%)
7,333 (4.4%) 18,397 
(11.1%)
4,610 (2.8%) 2,008 (1.2%) 1,033 (0.6%) 1,609 (1.0%) 1,650 (1.0%) 165,242
Ealing 176,741 
(58.7%)
73,851 
(24.5%)
26,456 
(8.8%)
13,020 
(4.3%)
3,022 (1.0%) 1,353 (0.4%) 3,629 (1.2%) 2,876 (1.0%) 300,948
Hounslow 137,754 
(64.9%)
52,510 
(24.7%)
9,237 (4.4%) 6,393 (3.0%) 1,382 (0.7%) 843 (0.4%) 2,407 (1.1%) 1,815 (0.9%) 212,341
Total 443,097 
(65.3%)
133,694 
(19.7%)
54,090 
(8.0%)
24,023 
(3.5%)
6,412 (0.9%) 3,229 (0.5%) 7,645 (1.1%) 6,341 (0.9%) 678,531
Source: 2001 CensusInternational Journal for Equity in Health 2007, 6:8 http://www.equityhealthj.com/content/6/1/8
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there was not a reliable means of doing so. The cut-off
points chosen for the intermediate outcomes of BP, total
cholesterol and HbA1c levels are derived from the 2002
NICE diabetes guidelines [13,14]. The 2002 NICE guid-
ance recommends a range of 6.5–7.5% for HbA1c and the
diabetes NSF refers to an optimal level of 7.0%. The guid-
ance recommends achieving a BP of 140/80, so we used a
BP cutoff of < 145 systolic. The most recent values in the
last five years were analysed.
Statistical methods
To test for the differences between ethnic groups, the
Kruskal-Wallis test was used for age and body mass index
(BMI) because they were non-normally distributed, and
the Chi-square test for categorical variables. The p-value is
for a test including the extra 'not recorded' category for
ethnicity and for the variable of interest, if categorical i.e.
the Chi-square test excludes the missing value category.
Results
A total of 21,343 patients were identified with a diagnosis
of either Type 1 or Type 2 diabetes. Table 2 shows the age
structure of the resident population in the three Boroughs.
Compared to the United Kingdom, they contain a higher
proportion of working age population and a lower pro-
portion of the older population.
Table 3 shows the ethnic group classification (using Read
codes for 1991 Census categories) of the diabetic popula-
tion recorded in GP systems in August 2002. Seventy per
cent had a valid ethnic code. The corresponding figure in
March 2001 was 60 percent. However, although there is a
Read code for "Other Ethnic Groups", there is no defini-
tion in the 1991 Census for the composition of this group,
so that only 64 per cent had usable codes. As the data was
anonymised for confidentiality reasons, we were unable
to employ software which uses surnames to assign ethnic-
ity. Unfortunately ethnicity recording in the entire GP reg-
istered population was too low to be used to assess
prevalence in each ethnic group. However while only 21
percent of the resident population is Asian or White &
Asian, 41 percent of the diabetic population with ethnic-
ity coded was South Asian.
Table 4 shows the descriptive, process or treatment meas-
ures and intermediate outcome measures by ethnic group.
The White diabetes patient population was substantially
older, in line with the population age structure. There
were substantially more female patients in the Black Afri-
can/Afro-Caribbean group. There were significantly less
smokers in the South Asian population. Patients with eth-
nicity not recorded have poorer quality of recording over-
all, with a substantially higher percentage of missing
values across all variables. They also have poorer out-
comes for blood pressure control, total cholesterol and
HbA1c. There is insufficient information in our dataset
e.g. numbers of attendances to investigate the reasons for
these findings further.
Total cholesterol, HbA1c, and insulin prescription were
recorded less often for South Asians, and the latter two
were also recorded less often for the Other ethnic group.
In that there is no Census definition, the Other ethnic
group could be seen as a proxy for relatively poor quality
of data recording.
There were significant differences in the proportion of
insulin-treated patients, with a smaller proportion of
South Asians receiving insulin, although the proportion
of South Asians with a satisfactory HbA1c is smaller. We
therefore expected higher insulin prescribing. On the
other hand, prescribing of statins is significantly higher in
South Asians, although there is no significant difference in
the proportion of patients with a total cholesterol less
than 5 mmol/l. A significantly higher proportion of Black
Africans/Afro-Caribbeans have an abnormally high systo-
lic blood pressure.
Discussion
By 2002, about 70 per cent of diabetic patients in NW
London had an ethnic group recorded in their electronic
care record, although six per cent of these had a category
of "Other". This was a 10 percent improvement over the
prior 15 months. Although we know that patients with a
chronic disease are more likely to have ethnicity recorded,
this result was achieved with only moderate levels of train-
ing, support and encouragement to GP practices, and
Table 2: Summarised mid-2002 population estimates in selected age groups for residents of the three London Boroughs and the 
United Kingdom, in thousands
Area/Borough All Ages Children 0–15 Working Age 16–64M/
59F
65M/60F and over
United Kingdom 59,321.7 11,783.4 (19.9%) 36,622.0 (61.7%) 10,916.3 (18.4%)
Hammersmith and Fulham 172.7 27.8 (16.1%) 124.4 (72.0%) 20.5 (11.9%)
Ealing 307.8 58.9 (19.1%) 208.3 (67.7%) 40.6 (13.2%)
Hounslow 215.4 43.0 (20.0%) 144.1 (66.9%) 28.3 (13.1%)
Source: ONS Projections From 2001 CensusInternational Journal for Equity in Health 2007, 6:8 http://www.equityhealthj.com/content/6/1/8
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before ethnicity recording of new patients was incentiv-
ised through the GP Contract Quality & Outcomes Frame-
work. We would therefore expect further improvements to
have occurred recently.
There is a high level of awareness of the importance of eth-
nicity as a disease risk factor, and many practices appear to
be using ethnicity as an indicator of risk for clinical man-
agement purposes already. It is clearly feasible to extend
the recording of ethnicity at the time of new patient regis-
tration to all patients with QOF diseases across the UK as
a next step.
Some classification bias could have occurred in our study
if patients from ethnic minorities were more or less likely
to have their ethnic group coded. However the relatively
high level of coding reduces error from this source. Our
findings suggest that lack of recording is a proxy for over-
all poor quality of recording and of clinical care.
A previous UK study of prescribing data showed that
patients in practices with a greater South Asian population
are less likely to be prescribed lipid-lowering drugs [15],
and another that GP prescribing rates in some PCTs were
negatively associated with proxies of healthcare need
based on patient age, ethnicity, levels of deprivation, and
standardised mortality ratios (SMRs) for CHD [16]. A sub-
sequent analysis of data from the Health Survey for Eng-
land showed an association between deprivation and
lower prescribing, but not ethnicity, highlighting the well-
known interaction between these two variables [17].
The Scottish hospital clinic study (which included only
1700 patients) showed South Asians had fewer prescrip-
tions of anti-hypertensive agents and lipid-lowering
agents and significantly smaller improvements in blood
pressure and cholesterol [6]. In contrast our data shows
similar levels of statin prescribing in all patients except in
Black Africans/Afro-Caribbeans, in whom it is signifi-
cantly lower, while proportions with a normal cholesterol
are not significantly different in all ethnic groups. Since
the local White population is significantly older, we
expected a smaller proportion to have a normal blood
pressure, but differences between the groups with ethnic-
ity coded is small, suggesting poorer outcomes in minor-
ity ethnic groups. Overall there does not appear to be a
consistent picture for these processes and outcomes in
diabetic patients.
For blood glucose control, an overall comparison with a
Swedish population-based study suggests that, in the out-
come of care is somewhat poorer in NW London [18]. In
the Swedish population, only 40 per cent had an HbA1c
greater than 7.5 per cent, while in NW London the propor-
tion was 59 per cent of those with HbA1c recorded, for all
ethnic groups. We consider that these findings are proba-
bly typical of similar UK populations.
A study from North Eastern USA [3] showed significantly
higher HbA1c in Black women but not Black men with
established diabetes, although a significantly higher pro-
portion were insulin-treated. The proportion of UK Afro-
Caribbeans who had achieved the target HbA1c fell
between those of the other two ethnic groups, and the
proportion who were insulin-treated was similar to
Whites. In the other US study from the TRIAD group [4]
mean HbA1c was higher in the ethnic minority patients. It
was not possible to compare insulin treatment from the
data provided in this study, or to analyse South Asians
separately.
Although the proportion of South Asian patients with
good diabetes control is significantly lower in our popula-
tion, a lower proportion are receiving insulin. This could
Table 3: Ethnic group of diabetic population recorded in GP systems
ETHNICITY Freq Percent
White 6,229 29.2%
Indian 4,478 21.0%
Bangladeshi 118 0.6%
Pakistani 913 4.3%
South Asian 5,509 25.8%
Black African 413 1.9%
Black Afro-Caribbean 1,160 5.4%
Black, Other 133 0.6%
Black African/Afro-Caribbean 1,706 8.0%
Chinese 121 0.6%
Other Ethnic Groups 1,355 6.3%
Uncoded 6,423 30.1%
TOTAL 21,343 100.0%International Journal for Equity in Health 2007, 6:8 http://www.equityhealthj.com/content/6/1/8
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be due to poorer patient concordance with treatment (or
GPs' perceptions of concordance) [19], or other undetec-
ted differences in practices' quality of care, such as less
intensive management because of outdated knowledge.
The low proportion of GP-based diabetic patients on insu-
lin was probably typical for NW London in 2002. Insulin
use in secondary care for type 2 diabetes has risen in the
last 5–10 years, but in primary care the initiation of insu-
lin has risen more slowly, and has only accelerated in the
last 2 years following the use of once daily long acting
insulin with the simultaneous use of oral agents. Primary
care services are free in the UK, the vast majority of the
population is registered with a GP, and most receive free
prescriptions. However while deprived UK populations
have higher utilisation rates for unscheduled care, this is
not the case for preventive primary care. This is probably
due to a mixture of patient-and provider-related factors
such as lower health literacy, and poorer care standards in
deprived areas. For example, some South Asians patients
with DM have ambivalent attitudes to diabetic treatments,
and so may be more reluctant to start insulin [19]. We
consider that this demonstrates poorer standards of care
in South Asians, but that institutional racism is unlikely to
be a major cause, as many South Asian patients are regis-
tered with GPs from their own ethnic group.
It is also possible that South Asians respond less well to
anti-diabetic agents. Levels of glucose intolerance, central
obesity (as measured by waist to hip ratio), fasting triglyc-
eride, and insulin are uniformly elevated in South Asians
compared to Europeans [20]. These factors are key fea-
tures of the insulin resistance syndrome, and probably
explain the higher prevalence of diabetes in this group.
However there are no previous population-based reports
Table 4: Descriptive, treatment and intermediate outcome measures by ethnic group
Ethnic Group N (%)
White South Asian Black African/
Afro-Caribbean
Other Not recorded p-value*
Descriptive Measures
Mean Age 65.4 59.7 62.8 58.9 61.8 p < 0.001
Median (IQR) (54.2–74.4) (50.2–67.6) (52.3–69.4) (49.4–67.9) (49.2–71.7)
Sex N (%)
Male 3463 (55.4) 3140 (56.6) 778 (45.9) 750 (53.7) 3507 (54.4) p < 0.001
Female 2775 (44.4) 2381 (42.9) 913 (53.8) 638 (45.7) 2900 (45.0)
Not recorded 15 (0.2) 30 (0.5) 6 (0.4) 9 (0.6) 38 (0.6)
Mean BMI  28.7 27 28.5 27.3 27.3 p < 0.001
Median(IQR) (25.2–33.0) (24.3–30.4) (25.5–32.2) (24.6–31.1) (24.2–31.2)
Not recorded 
N(%)
870(13.9) 495(8.9) 233 (13.73) 195 (14.0) 2361(36.6)
Smoker N(%) 1152 (18.4) 389 (7.0) 190 (11.2) 179 (12.8) 822 (12.8) p < 0.001
Not recorded 281 (4.5) 430 (7.8) 82 (4.8) 94 (6.7) 1508 (23.4) p < 0.001
Treatment Measures
On insulin N (%) 443 (7.1) 263 (4.7) 126 (7.4) 80 (5.7) 592 (9.2) p < 0.001
On statins N (%) 1860 (29.8) 1744 (31.4) 425 (25.0) 399 (28.6) 1405 (21.8) p < 0.001
Intermediate Outcome Measures
HbA1c < 7.4 N 
(%)
2368 (37.9) 1423 (25.6) 540 (31.8) 438 (31.4) 1354 (21.0) p < 0.001
Not recorded 1100 (17.6) 1377 (24.8) 313 (18.4) 320 (22.9) 3248 (50.4)
BP < = 145 N 
(%)
4094 (65.5) 3711 (66.9) 1095 (64.5) 995 (71.2) 3604 (55.9) p < 0.001
Not recorded 119 (1.9) 57 (1.0) 21 (1.2) 32 (2.3) 1035 (16.1)
Cholesterol < = 
5 N(%)
2537 (40.6) 2275 (41.0) 711 (41.9) 580 (41.5) 1609 (25.0) 0.038
Not recorded 1056 (16.9) 1154 (20.8) 265 (15.6) 226 (16.2) 2953 (45.8) p < 0.001
* note that the Chi-square tests for care process and intermediate outcome measures exclude the missing value categoryPublish with BioMed Central    and   every 
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documenting ethnic differences in metabolic responsive-
ness to anti-diabetic agents. This highlights the need to
capture ethnicity data in clinical trials as well as in routine
care, and to specifically investigate the reasons for these
ethnic differences by monitoring outcomes in popula-
tions with the same standards of care.
Conclusion
We have reported for the first time on the process and out-
comes of diabetes care in a population-based study using
ethnicity data captured during routine primary care.
About 70% of patients in NW London have valid ethnicity
codes. Diabetes control was significantly worse in South
Asians, but a smaller proportion of this group were insu-
lin treated. We have therefore confirmed earlier reports in
clinic populations in a much larger, population-based
group that some outcomes of care- in particular blood glu-
cose control- are worse in some UK ethnic minority
groups. We have shown that this is at least partly due to
poorer standards of care in South Asians, although biolog-
ical factors could also contribute. Further studies are
required to determine the extent to which provider or
patient factors- behavioural or biological- are responsible.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
MS managed the original project from which the data was
obtained and wrote the article text. AM provided ongoing
advice on analysis and drafting. JE carried out the statisti-
cal analysis. AD commented on final drafts. We acknowl-
edge the help of Phil Kirby and Dominic Clarke, who
extracted the data. All authors have read and approved the
final manuscript.
References
1. Health Survey for England- The Health of Minority Ethnic
Groups 1999  2001 [http://www.archive.official-documents.co.uk/
document/doh/survey99/hses-00.htm]. London: The Stationery
Office Last accessed on 03/08/2007.
2. Lanting LC, Joung IMA, Mackenbach JP, Lamberts SWJ, Bootsma AH:
Ethnic differences in mortality, end-stage complications, and
quality of care among diabetic patients.  Diabetes Care 2005,
28:2280-2288.
3. Adams AS, Zhang F, Mah C, Grant RW, Kleinman K, Meigs JB, Ross-
Degnan D: Race differences in long-term diabetes manage-
ment in an HMO.  Diabetes Care 2005, 28:2844-2850.
4. Brown AF, Gregg EW, Stevens MR, Karter AJ, Weinberger M, Safford
MM, Gary DL, Caputo DA, Waitzfelder B, Kim C, Beckles GL: Race,
ethnicity, socioeconomic position, and quality of care for
adults with diabetes enrolled in managed care: the Translat-
ing Research Into Action for Diabetes (TRIAD) study.  Diabe-
tes Care 2005, 28:2864-2873.
5. Chowdhury TA, Lasker SS, Mahfuz R: Ethnic differences in con-
trol of cardiovascular risk factors in patients with type 2 dia-
betes attending an Inner London diabetes clinic.  Postgrad Med
J 2006, 82:211-215.
6. Mukhopadhyay B, Forouhi NG, Fisher BM, Kesson CM, Sattar N: A
comparison of glycaemic and metabolic control over time
among South Asian and European patients with Type 2 dia-
betes: results from follow-up in a routine diabetes clinic.  Dia-
bet Med 2006, 23:94-98.
7. McElduff P, Edwards R, Burns JA, Young RJ, Heller R, Long B, Jones G,
New JP: Comparison of processes and intermediate out-
comes between South Asian and European patients with dia-
betes in Blackburn, north-west England.  Diabet Med 2005,
22:1226-1231.
8. National Clinical Audit Support Programme: National diabetes
audit: report for the audit period 2003–4. Health & Social
Care Information Centre website.  2005 [http://www.icserv
ices.nhs.uk/ncasp/pages/audit_topics/diabetes/default-new.asp]. Last
accessed on 03/08/2007
9. Goyder E, Hammersley V: Explaining variations in reported dia-
betes prevalence in general practice: how much variation is
explained by differences between practice populations?  Br J
Gen Practice 2003, 53(493):642-644.
10. Hippisley-Cox J, O'Hanlon S, Coupland C: Association of depriva-
tion, ethnicity, and sex with quality indicators for diabetes:
population based survey of 53 000 patients in primary care.
Br Med J 2004, 329:1267-1269.
11. Department of Health: National Service Framework for Diabe-
tes.  2001 [http://www.dh.gov.uk/PublicationsAndStatistics/Publi
caons/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuid-
anceArticle/fs/en?CONTENT_ID=4002951&chk=09Kkz1]. London:
Department of Health Last accessed on 03/08/2007.
12. NHS Employers website   [http://www.nhsemployers.org/pri
mary/primary-902.cfm]. Last accessed on 03/08/2007.
13. National Institute for Clinical Excellence (NICE): Management of
type 2 diabetes: management of blood pressure and blood
lipids.  2002 [http://www.nice.org.uk/page.aspx?o=38551]. London:
NICE Last accessed on 03 August 2007.
14. National Institute for Clinical Excellence (NICE): Management of
type 2 diabetes: management of blood glucose.  2002 [http://
www.nice.org.uk/page.aspx?o=36733]. London: NICE last accessed
on 03 August 2007.
15. Patel MG, Wright DJ, Gill PS, Jerwood D, Silcock J, Chrystyn H: Pre-
scribing of lipid lowering drugs to South Asian patients: eco-
logical study.  Br Med J 2002, 325:25-26.
16. Ward PR, Noyce PR, St Leger AS: Are GP practice prescribing
rates for coronary heart disease drugs equitable? A cross
sectional analysis in four primary care trusts in England.  J Epi-
demiol Comm Health 2004, 58:89-96.
17. Gill PS, Quirke TP, Mant JW, Allan TF: The use of lipid-lowering
drugs across ethnic groups in the secondary prevention of
ischaemic heart disease: analysis of cross-sectional surveys in
England.  Br J Gen Pract 2004, 54:442-3.
18. Farnkvist LM, Lundman BM: Outcomes of diabetes care: a popu-
lation-based study.  Int J Quality in Health Care 2003, 15:301-7.
19. Lawton J, Ahmad N, Hallowell N, Hanna L, Douglas M: Perceptions
and experiences of taking oral hypoglycaemic agents among
people of Pakistani and Indian origin: qualitative study.  Br
Med J 2005, 330:1247.
20. Chaturvedi N: Ethnic differences in cardiovascular disease.
Heart 2003, 89:681-6.